Development of a Wilms' Tumor Antigen-Specific T-Cell Receptor for Clinical Trials: Engineered Patient's T Cells Can Eliminate Autologous Leukemia Blasts in NOD/SCID Mice
Haematologica - Italy
doi 10.3324/haematol.2009.006486
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 13, 2009
Authors
Publisher
Ferrata Storti Foundation (Haematologica)